Adherence to pancreatic enzyme replacement therapy in patients with chronic pancreatitis: Current status and risk factors
World Chinese Journal of Digestology · 28.04.2026 · 34 (4) · 331-337
DOI: 10.11569/wcjd.v34.i4.331 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Chinese Journal of Digestology, erschienen am 28.04.2026. Verfasst von Can-Can Dai und 8 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dai, C., Liu, M., Zhang, S., Xu, J., Zhou, X., Yang, F., Jiang, L., Hu, L., & Liu, C. (2026). Adherence to pancreatic enzyme replacement therapy in patients with chronic pancreatitis: Current status and risk factors. World Chinese Journal of Digestology, 34(4), 331-337. https://doi.org/10.11569/wcjd.v34.i4.331
Vancouver
Dai C, Liu M, Zhang S, Xu J, Zhou X, Yang F, et al. Adherence to pancreatic enzyme replacement therapy in patients with chronic pancreatitis: Current status and risk factors. World Chinese Journal of Digestology. 2026;34(4):331-337. doi:10.11569/wcjd.v34.i4.331
BibTeX
@article{Dai2026,
author = {Dai, Can-Can and Liu, Miao and Zhang, Song-Lin and Xu, Jin-Jie and Zhou, Xiao-Yu and Yang, Fan and Jiang, Ling-Ying and Hu, Liang-Hao and Liu, Cui},
title = {Adherence to pancreatic enzyme replacement therapy in patients with chronic pancreatitis: Current status and risk factors},
journal = {World Chinese Journal of Digestology},
year = {2026},
volume = {34},
number = {4},
pages = {331--337},
doi = {10.11569/wcjd.v34.i4.331}
}
EUVIMED